Fingerprint
Dive into the research topics where Dov Gavish is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comparative Pharmacokinetic Assessment of Innovative Sublingual, Rectal and Vaporizer Cannabis Products Versus Approved Cannabis Products in Healthy Volunteers
Tarlovski, S., Bar Kadmon, A., Goldberg, E., Segal, D., Gavish, D. & Stepensky, D., 1 Apr 2025, In: Cannabis and Cannabinoid Research. 10, 2, p. e289-e298Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Banach, M., Reiner, Ž., Surma, S., Bajraktari, G., Bielecka-Dabrowa, A., Bunc, M., Bytyçi, I., Ceska, R., Cicero, A. F. G., Dudek, D., Dyrbuś, K., Fedacko, J., Fras, Z., Gaita, D., Gavish, D., Gierlotka, M., Gil, R., Gouni-Berthold, I., Jankowski, P. & Járai, Z. & 25 others, , Dec 2024, In: Drugs. 84, 12, p. 1541-1577 37 p., 107246.Research output: Contribution to journal › Review article › peer-review
Open Access35 Scopus citations -
Hemoglobin A1C as a prognostic factor and the pre-diabetic paradox in patients admitted to a tertiary care medical center intensive cardiac care unit: The Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-6) study group
Lupu, L., Taha, L., Farkash, R., Bayya, F., Karmi, M., Steinmetz, Y., Shaheen, F. F., Perel, N., Hamayel, K., Levi, N., Maller, T., Karameh, H., Lichewitz, G., Gavish, D., Algur, N., Glikson, M. & Asher, E., Dec 2022, In: Cardiovascular Diabetology. 21, 1, 86.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Association of contemporary statin pretreatment intensity and ldl-c levels on the incidence of stemi presentation
Dadon, Z., Moriel, M., Iakobishvili, Z., Asher, E., Samuel, T. Y., Gavish, D., Glikson, M. & Gottlieb, S., Nov 2021, In: Life. 11, 11, 1268.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
ODYSSEY OUTCOMES Committees and Investigators, 3 Aug 2021, In: Journal of the American College of Cardiology. 78, 5, p. 421-433 13 p.Research output: Contribution to journal › Article › peer-review
Open Access111 Scopus citations